{"id":"https://openalex.org/W7204015602","doi":null,"title":"Tisotumab vedotin for treating recurrent or metastatic cervical cancer that has progressed on or after systemic treatment: a single technology appraisal","display_name":"Tisotumab vedotin for treating recurrent or metastatic cervical cancer that has progressed on or after systemic treatment: a single technology appraisal","alternate_titles":[],"publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W7204015602"},"language":"en","primary_location":{"id":"pmh:oai:eprints.soton.ac.uk:513443","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/513443/1/Tisotumab_Vedotin_EAG_report.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/513443/1/Tisotumab_Vedotin_EAG_report.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"},"parent_works":[],"lineage":["https://openalex.org/W7204015602"],"child_works_count":0,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009417975","display_name":"Karen Pickett","orcid":"https://orcid.org/0000-0002-8631-6465","observed_orcids":["https://orcid.org/0000-0002-8631-6465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pickett, Karen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038243124","display_name":"Mary Onoja","orcid":"https://orcid.org/0009-0005-4792-8505","observed_orcids":["https://orcid.org/0009-0005-4792-8505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Onoja, Mary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072527393","display_name":"Joanna Picot","orcid":"https://orcid.org/0000-0001-5987-996X","observed_orcids":["https://orcid.org/0000-0001-5987-996X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Picot, Joanna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064976644","display_name":"M\u00e1rcia Takahashi","orcid":"https://orcid.org/0000-0002-6932-2660","observed_orcids":["https://orcid.org/0000-0002-6932-2660"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takahashi, Marcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032470152","display_name":"Joanne Lord","orcid":"https://orcid.org/0000-0003-1086-1624","observed_orcids":["https://orcid.org/0000-0003-1086-1624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lord, Joanne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.7778000235557556,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.12489999830722809,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tisotumab-vedotin","display_name":"tisotumab vedotin","score":1.0},{"id":"https://openalex.org/keywords/recurrent-cervical-cancer","display_name":"recurrent cervical cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/metastatic-cervical-cancer","display_name":"metastatic cervical cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5139999985694885},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.6930000185966492},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/technology-appraisal","display_name":"technology appraisal","score":0.5569999814033508},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9218000173568726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7160000205039978},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.685699999332428},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6679999828338623},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.40799999237060547},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32100000977516174},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2915000021457672},{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.2743000090122223},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2694000005722046},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26460000872612},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2533999979496002},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2526000142097473},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.25060001015663147}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:eprints.soton.ac.uk:513443","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/513443/1/Tisotumab_Vedotin_EAG_report.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/513443/1/Tisotumab_Vedotin_EAG_report.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400882456","https://openalex.org/W4403251372","https://openalex.org/W4387107218","https://openalex.org/W7164051357","https://openalex.org/W4319873434","https://openalex.org/W4410477727","https://openalex.org/W4411225151","https://openalex.org/W3155156689","https://openalex.org/W3171855462","https://openalex.org/W4400270342"],"abstract_inverted_index":{"This":[0],"report":[1],"critiques":[2],"the":[3],"company":[4],"submission":[5],"(CS)":[6],"for":[7,11],"tisotumab":[8],"vedotin":[9],"monotherapy":[10],"treating":[12],"recurrent":[13],"or":[14,22],"metastatic":[15],"cervical":[16],"cancer":[17],"that":[18],"has":[19],"progressed":[20],"on":[21],"after":[23],"systemic":[24],"treatment.":[25]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204015602","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2026-08-23T00:00:00"}
